Kelly Bryant, BSN, RN

Kelly Bryant, BSN, RN, is a Regulatory Affairs Principal at NMDP with over two decades of experience in clinical research, regulatory compliance, and quality systems. Her career includes extensive work at the National Cancer Institute supporting early-phase oncology trials, regulatory submissions, and cross-functional coordination. Ms. Bryant’s expertise includes Good Tissue Practice (GTP), FDA regulations under 21 CFR 1271, and the development and implementation of regulatory training and process improvement initiatives. She has contributed to peer-reviewed publications in hematologic malignancies and cell therapy, and remains engaged in advancing regulatory standards for cellular and tissue-based product development and oversight.